These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10954)

  • 21. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
    Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
    J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of labetalol, propranolol and practolol in patients with asthma.
    Larsson K
    Eur J Respir Dis; 1982 May; 63(3):221-30. PubMed ID: 6124442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Labetalol. Current research and therapeutic status.
    Wallin JD; O'Neill WM
    Arch Intern Med; 1983 Mar; 143(3):485-90. PubMed ID: 6338850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Labetalol in long-term treatment of hypertension.
    Prichard BN; Boakes AJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of labetalol and YM-09538 on neuronal uptake of (3H)norepinephrine in the rat vas deferens.
    Cohen ML; Hynes LM
    Clin Exp Hypertens A; 1983; 5(4):563-75. PubMed ID: 6133660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha- and beta-blocking activities of racemates of labetalol.
    Nakagawa Y; Shimamoto N; Nakazawa M; Imai S
    Jpn J Pharmacol; 1980 Oct; 30(5):743-5. PubMed ID: 6110798
    [No Abstract]   [Full Text] [Related]  

  • 27. The pharmacological basis for the use of labetalol in the treatment of hypertension.
    Prichard BN; Richards DA
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S24-9. PubMed ID: 6169957
    [No Abstract]   [Full Text] [Related]  

  • 28. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Labetalol blockade of central alpha- and beta-noradrenergic receptors in rat brain homogenates.
    Devoto P; Stefanini E; Marchisio AM; Vernaleone F; Collu R
    Pharmacol Res Commun; 1980 Feb; 12(2):177-82. PubMed ID: 6104337
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalol.
    Gold EH; Chang W; Cohen M; Baum T; Ehrreich S; Johnson G; Prioli N; Sybertz EJ
    J Med Chem; 1982 Nov; 25(11):1363-70. PubMed ID: 6128421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Giant, dopamine secreting thoracoabdominal neuroblastoma in a 2-year-old: rapid preoperative blockade with labetalol.
    Pappas L; Shamberger RC; Seefelder C
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):163-6. PubMed ID: 20147848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
    Nami R; Pizzuti M; Nardi PL; D'Ascenzo G; Maioli E; Gennari C
    Boll Soc Ital Cardiol; 1980; 25(7):763-8. PubMed ID: 6115658
    [No Abstract]   [Full Text] [Related]  

  • 33. [Orthostatic hypotension in patients with antihypertensive combination therapy].
    Holzgreve H
    MMW Fortschr Med; 2009 Jun; 151(26-29):29-30. PubMed ID: 19739543
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].
    Stummvoll HK
    Wien Med Wochenschr Suppl; 1981; 69():14-6. PubMed ID: 6123200
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Labetalol in hypertension.
    Louis WJ; Brignell MJ; McNeil JJ; Christophidis N; Vajda FJ
    Lancet; 1978 Feb; 1(8061):452-3. PubMed ID: 75487
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
    Steinrauf LK; Schulz AR; Ryder KW; Brunn PW; Cook D; Judy W
    Indiana Med; 1985 Jul; 78(7):600-4. PubMed ID: 2863304
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol].
    Gérard J; Blazquez G; Mounac M; Giraud P; Jeuffroy A; Lardoux H
    Rev Fr Gynecol Obstet; 1984 Nov; 79(11):713-7. PubMed ID: 6152500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive aminotetralins related to labetalol and medroxalol.
    Clark RD; Caroon JM; Repke DB; Strosberg AM; Whiting RL; Brown CM
    J Pharm Sci; 1986 Jan; 75(1):80-2. PubMed ID: 3007731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of labetalol in producing deliberate hypotension and its effects on intracranial pressure in dogs.
    Van Aken H; Puchstein C; Hidding J
    Acta Anaesthesiol Belg; 1982; 33(1):5-12. PubMed ID: 7090725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.